Summary
- Current Price
- As of today, AVBP price is $30.99, up +0.49% on
- Current Price All-Time High
- AVBP price is currently -14.79% below its historical high of $36.37 set on
- Market Cap
- AVBP current market cap is $1B, up +121.39% over the past 365 days
- Revenue
- AVBP current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for AVBP is on
Profile
| Metric | Value |
|---|---|
| Full Name | ArriVent BioPharma, Inc. |
| Ticker | NASDAQ: AVBP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | arrivent.com |
| Employees | 52 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $30.99 | |
| Price, 1D Change | +0.49% | |
| $1B | ||
| - | ||
| - | ||
| 1.18 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.32 | ||
| EPS, 1Y Change | -81.08% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$4.32 | ||
| EPS Estimate | -$4.09 | N/A |
| EPS Est. Change | +5.45% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $30.99 | |
| Price Target | $45.00 | - |
| Price Tgt. Change | +45.21% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.69 | -$2.39 | +11.33% | |
| -$4.28 | -$4.32 | -0.94% | |
| -$4.09 | N/A | +5.45% | |
| -$3.48 | N/A | +19.53% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $47.00M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $30.99 | |
| $25.65 | ||
| $31.69 | ||
| $27.00 | ||
| $30.91 | ||
| -$0.32 | ||
| 1.18 | ||
| $1.86 | ||
| 49.17 | ||
| 41.19% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$4.32 | ||
| $0.00 | ||
| - | ||
| -$177.53M | ||
| - | ||
| -$166.31M | ||
| - | ||
| -$177.53M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 12.83 | ||
| 12.83 | ||
| - | ||
| - | ||
| 31.03 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 4.46 | ||
| -7.12 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $307.22M | ||
| $312.82M | ||
| $333.17M | ||
| $332.90M | ||
| $25.95M | ||
| $25.95M | ||
| $14.00K | ||
| $14.00K | ||
| $5.93M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $166.31M | ||
| $177.53M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$160.59M | ||
| -$71.23M | ||
| $203.06M | ||
| $0.00 | ||
| -$160.59M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Truist Securities | → | |
| Citigroup | → | |
| Citigroup | → | |
| B. Riley Securities | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| Cantor Fitzgerald | ||
| BTIG | ||
| Truist Securities |
Analyst sentiment
Institutional ownership
Screeners with AVBP
FAQ
- What is the ticker symbol for ArriVent BioPharma, Inc.?
- The ticker symbol for ArriVent BioPharma, Inc. is NASDAQ:AVBP
- Does ArriVent BioPharma, Inc. pay dividends?
- No, ArriVent BioPharma, Inc. does not pay dividends
- What sector is ArriVent BioPharma, Inc. in?
- ArriVent BioPharma, Inc. is in the Healthcare sector
- What industry is ArriVent BioPharma, Inc. in?
- ArriVent BioPharma, Inc. is in the Biotechnology industry
- What country is ArriVent BioPharma, Inc. based in?
- ArriVent BioPharma, Inc. is headquartered in United States
- When did ArriVent BioPharma, Inc. go public?
- ArriVent BioPharma, Inc. initial public offering (IPO) was on January 26, 2024
- Is ArriVent BioPharma, Inc. in the S&P 500?
- No, ArriVent BioPharma, Inc. is not included in the S&P 500 index
- Is ArriVent BioPharma, Inc. in the NASDAQ 100?
- No, ArriVent BioPharma, Inc. is not included in the NASDAQ 100 index
- Is ArriVent BioPharma, Inc. in the Dow Jones?
- No, ArriVent BioPharma, Inc. is not included in the Dow Jones index
- When was ArriVent BioPharma, Inc. last earnings report?
- ArriVent BioPharma, Inc.'s most recent earnings report was on May 11, 2026
- When does ArriVent BioPharma, Inc. report earnings?
- The next expected earnings date for ArriVent BioPharma, Inc. is August 14, 2026
Data Sources & References
- AVBP Official Website arrivent.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1868279/000110465926024127/0001104659-26-024127-index.htm
- AVBP Profile on Yahoo Finance finance.yahoo.com/quote/AVBP
- AVBP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avbp